Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04284553 · ClinicalTrials.gov registry record · NA

Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults

A NA study of Aging and Adverse Drug Event, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
216
Enrollment target
1
Study location

NCT04284553 is a NA study of Aging and Adverse Drug Event that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 216 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04284553, a NA study of Aging and Adverse Drug Event, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
216 participants
Enrollment target
1
Study location

Study Summary

Prescribing of potentially unsafe medications for older adults is extremely common; benzodiazepines and sedative hypnotics are, for example, key drug classes frequently implicated in adverse health consequences for vulnerable older adults, such as confusion or sedation, leading to hospitalizations, falls, and fractures. Fortunately, most of these consequences are preventable. Physicians' lack of awareness of alternatives, ambiguous practice guidelines, and perceived pressure from patients or caregivers are among the reasons why these drugs are used more than might be optimal. Reducing inappropriate use of these drugs may be achieved through decision support tools for providers that are embedded in electronic health record (EHR) systems. While EHR strategies are widely used to support the informational needs of providers, these tools have demonstrated only modest effectiveness at improving prescribing. The effectiveness of these tools could be enhanced by leveraging principles of behavioral economics and related sciences.

Conditions Studied

Aging Adverse Drug Event Benzodiazepine Sedative Adverse Reaction Anticholinergic Adverse Reaction

Interventions

  • OTHER Order Entry
  • OTHER Open Encounter
  • OTHER Follow-up booster Alert
  • OTHER Cold State outreach
  • OTHER Simplified

Study Locations (1)

Massachusetts

  • Atrius Health - Braintree

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2020-10-13
Est. Completion 2022-08-31
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04284553

The ClinicalTrials.gov registry entry for NCT04284553 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (90% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 5 interventions - of which Order Entry is the first listed.

NCT04284553 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04284553 about?

NCT04284553 is a clinical study titled "Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults". Prescribing of potentially unsafe medications for older adults is extremely common; benzodiazepines and sedative hypnotics are, for example, key drug classes frequently implicated in adverse health consequences for vulnerable older adults, such as confusion or sedation, leading to hospitalizations, ...

What is the current status of trial NCT04284553?

This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2020-10-13. Estimated completion is 2022-08-31.

What conditions does trial NCT04284553 study?

This clinical trial studies the following conditions: Aging, Adverse Drug Event, Benzodiazepine Sedative Adverse Reaction, Anticholinergic Adverse Reaction.

What interventions are being tested in trial NCT04284553?

The interventions under investigation include: Order Entry (OTHER), Open Encounter (OTHER), Follow-up booster Alert (OTHER), Cold State outreach (OTHER), Simplified (OTHER).

Who is sponsoring clinical trial NCT04284553?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04284553 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aging

All registered trials for this condition

Adverse Drug Event

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.